WMJ Vol 123 Issue 5: Aim More Towards the Bed than the Head: A Proof of Concept Pilot Study on a Simple Technique for Keeping Trauma Thoracostomy Tubes Out of Lung Fissures

ABSTRACT

Introduction: Tube thoracostomy (TT) is used to drain the pleural cavity in the setting of both traumatic and nontraumatic pathologies. Literature has shown that inappropriate tube positioning occurs in 30% of patients, including TTs placed within the fissure, which may result in further interventions in these patients. Our goal was to compare the rates of TT placed into a lung fissure in a controlled model using a simple approach to direct the tube more toward the bed than the patient's head at the time of placement to validate further investigations of the clinical applicability of this technique.

Methods: We performed 650 tube thoracostomies in 3 separate cadaver torsos with tracheal intubation and bag valve mask approximating a 50% pneumothorax. TTs were performed by experienced clinicians using a "more toward the head" direction and a "more toward the bed" direction while varying other factors, including side of the chest, tube size, and location on the chest wall, followed by lung re-expansion to better evaluate each approach in different common clinical scenarios. A power analysis was performed for our primary outcome of tube placement in a lung fissure by direction, not for any additional variables. Multivariate analysis was used to determine whether the "head" or "bed" direction was more likely to result in tube placement in a fissure when controlling for other changes.

Results: A total of 650 TTs were placed in 3 cadavers by 2 experienced performers. The overall rate of tube placement in a fissure was 41% using the "head" direction and 13% using the "bed" direction. On multivariate analysis, the "bed" direction also was shown to have significantly decreased tube placement in a lung fissure when controlling for side, tube size, and location (P< 0.01; odds ratio 0.22; 95% CI, 0.14 - 0.33).

Conclusions: Aiming more toward the bed than toward the head during TT placement is associated with a significantly decreased chance of placing the TT within a lung fissure in this highly controlled cadaveric proof-of-concept model. This technique requires no changes to standard TT placement set-up, time, cost, or equipment. We propose that it warrants further investigation as a potential intervention to decrease malpositioned tubes.

Intended Audience

The intended audience for this continuing education activity is healthcare professionals caring for the people of Wisconsin and beyond.

Learning Objectives

As a result of participating in this journal-based activity, healthcare team members will be able to:    

  1. Describe complications associated with placement of a thoracostomy tube (TT) used to drain the pleural cavity of blood or air
  2. Discuss results of this study examining the rates of TT placed into a lung fissure using the patient's head direction versus the bed direction
  3. Provide rationale for implementing "more toward the bed" TT placement technique in training and practice. 
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit
  • 0.75 ANCC Contact Hours
  • 0.75 University of Wisconsin–Madison Continuing Education Hours
    • 0.75 Approved for AMA PRA Category 1 Credit™
Registration opens: 
08/04/2025
Course expires: 
08/03/2026
Cost:
$0.00
Rating: 
0

FACULTY DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

Name of IndividualIndividual's Role in ActivityFinancial Relationship DisclosureDiscussion of Unlabeled/Unapproved Uses of Drugs/Devices
Marianna Shershneva, MD, PhDAccreditation SpecialistNo relevant relationships with ineligible companies to discloseNo
James Eberhard, MFAAccreditation SpecialistNo relevant relationships with ineligible companies to discloseNo

Jacob Peschman, MD

AuthorNo relevant relationships with ineligible companies to discloseNo
Alec J. Fitzsimmons, MPHAuthorNo relevant relationships with ineligible companies to discloseNo
Andrew J. Borgert, PhDAuthorNo relevant relationships with ineligible companies to discloseNo
Carley S. Buisman, CHSEAuthorNo relevant relationships with ineligible companies to discloseNo
Christine J. Waller, MDAuthorNo relevant relationships with ineligible companies to discloseNo
Faraz A. Khan, MDAuthorNo relevant relationships with ineligible companies to discloseNo
Thomas Carver, MDReviewerCytovale, Inc (Independent Contractor - Consultant),
Innovital, Inc (Independent Contractor - Other)
No
Amy E. Liepert, MDReviewerNo relevant relationships with ineligible companies to discloseNo
Fahad Aziz, MDEditorNo relevant relationships with ineligible companies to discloseNo
Katie Gillespie, DNP, RN, CPH, FAANReviewerNo relevant relationships with ineligible companies to discloseNo
Cassie Meffert, PAC, MPHReviewerNo relevant relationships with ineligible companies to discloseNo
David Dwyer, PhD, RN, NEBCReviewerNo relevant relationships with ineligible companies to discloseNo

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.

Discloser List CME Internal Report

Accreditation Statement

Accreditation LogosAccreditation Statements
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal.  The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

 

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 0.75 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 0.75 ANCC contact hours.

 

Continuing Education Units

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.075 continuing education units (CEUs) or 0.75 hour.

 

Available Credit

  • 0.75 AMA PRA Category 1 Credit
  • 0.75 ANCC Contact Hours
  • 0.75 University of Wisconsin–Madison Continuing Education Hours
    • 0.75 Approved for AMA PRA Category 1 Credit™

Cost:
$0.00
Please login or register to take this course.

Accessibility

If you need anything to participate in this program, please contact [email protected].

Required Hardware/software

Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly. 

Free, current version of Adobe Acrobat Reader or other .pdf reader.